Elanco Animal Health (ELAN) Depreciation & Amortization (CF) (2017 - 2026)

Elanco Animal Health has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $171.0 million for Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) rose 1.18% year-over-year to $171.0 million; the TTM figure through Jun 2026 stood at $693.0 million (up 4.37% YoY), while the FY2025 annual figure was $680.0 million, up 2.72% from the prior year.
• Depreciation & Amortization (CF) came in at $171.0 million for Q2 2026 at Elanco Animal Health, down from $172.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $177.0 million in Q2 2023 to a low of $161.0 million in Q1 2025.
• Average Depreciation & Amortization (CF) over 5 years is $170.1 million, with a median of $171.0 million recorded in 2022.
• Year-over-year, Depreciation & Amortization (CF) fell 12.87% in 2022 and increased 6.83% in 2026.
• Over 5 years, Depreciation & Amortization (CF) stood at $168.0 million in 2022, then advanced by 1.79% to $171.0 million in 2023, then fell by 4.09% to $164.0 million in 2024, then climbed by 6.1% to $174.0 million in 2025, then slipped by 1.72% to $171.0 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $171.0 million in Q2 2026, $172.0 million in Q1 2026, and $174.0 million in Q4 2025.